Overview Financials News + Filings Key Docs Charts Ownership
|
|
KBL Healthcare Acquisition Corp III (KHA)
|
|
| Income Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-09 | Dec-31-08 | Sep-30-08 | Jun-30-08 | Mar-31-08 | Sep-30-07 | Jun-30-07 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | 0.0% | | 25.3% | | | | |
| Cost of goods sold | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | -1599.7% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Selling, general and administrative | 0.5 | 0.1 | 0.4 | 0.2 | 0.1 | 0.1 | 0.0 |
| Other operating expenses | 0.1 | -3.5 | -0.6 | -0.8 | -1.3 | -1.7 | 0.0 |
| EBITDA [+] | -0.5 | 3.1 | 0.2 | 0.6 | 1.2 | | |
| EBITDA growth | -144.0% | | -87.9% | -42864.4% | | | |
| EBITDA margin | -2974.7% | 17799.8% | 1126.4% | 3428.5% | 6759.5% | 11640.4% | |
| Depreciation and amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | |
| EBIT [+] | -0.5 | 3.1 | 0.2 | 0.6 | 1.2 | 1.6 | 0.0 |
| EBIT growth | -144.0% | | -87.9% | -42844.2% | | | |
| EBIT margin | -2976.3% | 17798.2% | 1121.6% | 3426.9% | 6758.0% | 11640.4% | |
| Interest expense | 0.1 | 1.9 | 0.4 | 0.5 | 0.8 | 0.9 | 0.0 |
| Interest expense | 0.1 | 1.9 | 0.4 | 0.5 | 0.8 | 0.9 | 0.0 |
| Other income (expense), net | | -1.6 | | | | | |
| Pre-tax income | -0.6 | -0.4 | -0.2 | 0.1 | 0.4 | 0.7 | 0.0 |
| Income taxes | 0.0 | -0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 |
| Tax rate | 0.0% | 48.1% | 8.5% | 70.8% | 7.4% | 20.9% | 0.0% |
| Net income | -0.6 | -0.2 | -0.2 | 0.0 | 0.3 | 0.6 | 0.0 |
| Net margin | -3457.9% | -1178.0% | -985.2% | 172.7% | 1934.0% | 4037.7% | |
| |
| Basic EPS [+] | ($0.03) | ($0.01) | ($0.01) | $0.00 | $0.02 | $0.03 | $0.00 |
| Growth | -250.0% | | -124.2% | -448.8% | | | |
| Diluted EPS [+] | ($0.03) | ($0.01) | ($0.01) | $0.00 | $0.02 | $0.03 | $0.00 |
| Growth | -250.0% | | -124.2% | -448.8% | | | |
| |
| Shares outstanding (basic) [+] | 20.2 | 21.0 | 21.0 | 21.0 | 16.9 | 16.6 | 3.8 |
| Growth | 19.2% | | 26.2% | 460.0% | | | |
| Shares outstanding (diluted) [+] | 20.2 | 21.0 | 21.0 | 21.0 | 16.9 | 16.6 | 3.8 |
| Growth | 19.2% | | 26.2% | 460.0% | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|